Our findings suggest that decreased cholinesterase levels and elevated MPV values may serve as promising biomarkers for PE diagnosis. Additionally, low cholinesterase levels appear to be associated with increased mortality risk in PE patients. These parameters, particularly cholinesterase, could potentially enhance current risk stratification tools when integrated with clinical scoring systems.
Building similarity graph...
Analyzing shared references across papers
Loading...
Medine Akkan-Öz
Hüseyin Mutlu
Bensu Bulut
Clinical Laboratory
Building similarity graph...
Analyzing shared references across papers
Loading...
Akkan-Öz et al. (Thu,) studied this question.
www.synapsesocial.com/papers/69d8946e6c1944d70ce0560f — DOI: https://doi.org/10.7754/clin.lab.2025.250916